 - Specific Aim 1: To test the primary hypothesis that participants receiving MBCT-PD will experience improved depressive outcomes compared to participants receiving OAR, including lower rates of depressive relapserecurrence and lower depressive symptom severity as compared to participants receiving OAR. 